Home › Companies › Surgery Partners, Inc. › 2025-2026

Surgery Partners, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Surgery Partners, Inc.’s Form 8-K, filed June 5, 2026 (Item 5.07 on EDGAR). Page generated October 18, 2026.

  • 5Ballot items
  • 206Asset managers
  • 1,203Fund votes
  • June 5, 2026Meeting date

Results at a glance

Meeting of June 5, 2026: 5 items on Surgery Partners, Inc.’s Form 8-K, filed June 5, 2026: 3 elected · 2 approved.

Material dissent

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Surgery Partners, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Surgery Partners, Inc.

These tallies are Surgery Partners, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 5, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Surgery Partners, Inc. — official shareholder meeting results, meeting held June 5, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Devin O'Reilly 90,059,419---- 23,613,7256,243,195 79%Elected—
Elect Director: Brent Turner 110,147,882---- 3,525,2626,243,195 97%Elected—
Elect Director: Laura L. Forese, M.D. 91,121,777---- 22,551,3676,243,195 80%Elected—
2. Advisory vote on executive compensation 111,639,0922,018,77715,275 --6,243,195 98%Approved—
3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026 119,828,74162,95024,648 ---- 99.9%Approved—

Source: Surgery Partners, Inc., Form 8-K, filed with the SEC on June 5, 2026 — read the filing on EDGAR.

How asset managers voted at the Surgery Partners, Inc. 2025-2026 meeting

Each item below shows how the 206 asset managers that disclosed a Surgery Partners, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Devin O'Reilly

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 4 wordings of this item as funds reported it.

79% Majority: yes · of votes cast

FOR 79%WITHHELD
FOR: 90,059,419WITHHELD: 23,613,725
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Class II Directors: Devin O'Reilly

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Devin O'Reilly”): 90,059,419 for, 23,613,725 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the director nominees to serve as a Class II director until the Company's 2029 annual meeting of stockholders and until each such successor has been elected and qualified.”
Support: 79% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 28,028,553 for, 2,361,672 withheld, 38 abstained.

FOR
FOR: 28,028,553ABSTAIN: 38WITHHOLD: 2,361,672
Largest asset managers voting on “Election of Class II Directors: Devin O'Reilly” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,005,3430 3810,863For
Legg Mason3,352,5800 00For
T. Rowe Price00 01,688,113Withhold
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 051,508Mixed
TIAA159,7970 00For
Principal Exchange-Traded Funds00 0139,374Withhold
WESMARK FUNDS00 0120,000Withhold
Lincoln Financial55,8020 027,195Mixed
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree00 046,618Withhold
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust00 040,738Withhold
Global X00 036,187Withhold
Bridge Builder Trust33,9840 00For
Goldman Sachs00 033,268Withhold
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

2. Elect Director: Brent Turner

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

97% Majority: yes · of votes cast

FOR 97%
FOR: 110,147,882WITHHELD: 3,525,262
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Class II Directors: Brent Turner

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Brent Turner”): 110,147,882 for, 3,525,262 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the director nominees to serve as a Class II director until the Company's 2029 annual meeting of stockholders and until each such successor has been elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 30,286,687 for, 103,570 withheld, 6 abstained.

FOR
FOR: 30,286,687ABSTAIN: 6WITHHOLD: 103,570
Largest asset managers voting on “Election of Class II Directors: Brent Turner” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,005,3750 610,863For
Legg Mason3,352,5800 00For
T. Rowe Price1,687,7910 0322For
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 051,508Mixed
TIAA159,7970 00For
Principal Exchange-Traded Funds139,3740 00For
WESMARK FUNDS120,0000 00For
Lincoln Financial75,2830 07,714Mixed
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree46,6180 00For
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust40,7380 00For
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

3. Elect Director: Laura L. Forese, M.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 5 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%WITHHELD
FOR: 91,121,777WITHHELD: 22,551,367
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Election of Class II Directors: Laura L. Forese, M.D.

Surgery Partners, Inc.’s own tally for this item (“Elect Director: Laura L. Forese, M.D.”): 91,121,777 for, 22,551,367 withheld, per its Form 8-K filed June 5, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “The stockholders elected each of the director nominees to serve as a Class II director until the Company's 2029 annual meeting of stockholders and until each such successor has been elected and qualified.”
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 28,162,456 for, 2,227,770 withheld, 37 abstained.

FOR
FOR: 28,162,456ABSTAIN: 37WITHHOLD: 2,227,770
Largest asset managers voting on “Election of Class II Directors: Laura L. Forese, M.D.” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,016,2070 370For
Legg Mason3,352,5800 00For
T. Rowe Price00 01,688,113Withhold
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable163,5940 051,508Mixed
TIAA159,7970 00For
Principal Exchange-Traded Funds00 0139,374Withhold
WESMARK FUNDS00 0120,000Withhold
Lincoln Financial55,8020 027,195Mixed
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree00 046,618Withhold
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust00 040,738Withhold
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

4. 2. Advisory vote on executive compensation

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 8 wordings of this item as funds reported it.

98% Approved · of votes cast

FOR 98%
FOR: 111,639,092AGAINST: 2,018,777
Details: description as filed, official tally, votes by 206 asset managers

Description as filed by funds: Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.

Surgery Partners, Inc.’s own tally for this item (“2. Advisory vote on executive compensation”): 111,639,092 for, 2,018,777 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders approved on a non-binding, advisory basis the compensation paid by the Company to its named executive officers, as disclosed in the Company's Definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on April 23, 2026.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 58 asset managers voting on “Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,016,2413 00For
Legg Mason3,352,5800 00For
T. Rowe Price1,688,1130 00For
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable215,1020 00For
TIAA159,7970 00For
Principal Exchange-Traded Funds139,3740 00For
WESMARK FUNDS120,0000 00For
Lincoln Financial82,9970 00For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree46,6180 00For
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust40,7380 00For
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Fund voting reports, all 58 managers: 30,383,790 for, 6,465 against. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 161 asset managers voting on “Approval, on an advisory basis, of the compensation paid by the Company to its named executive officers.” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
BAIN CAPITAL INVESTORS LLC49,946,9720 00For
Janus Henderson27,023,4280 00For
OAK RIDGE INVESTMENTS LLC12,146,7110 00For
Pentwater Capital Management LP12,146,7110 00For
Clearbridge Investments, LLC3,892,0080 00For
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP3,108,4380 00For
T. Rowe Price2,498,2110 00For
BlackRock1,833,6340 00For
GLENVIEW CAPITAL MANAGEMENT, LLC1,800,0000 00For
Charles Schwab1,108,1000 00For
Sea Cliff Partners Management, LP1,039,7990 00For
GEODE CAPITAL MANAGEMENT, LLC998,7400 00For
RAYMOND JAMES & ASSOCIATES799,3260 00For
Irenic Capital Management LP0711,000 00Against
State Street704,2570 00For
Fidelity685,5380 00For
John Hancock651,6770 00For
UBS630,5940 00For
Vanguard515,8710 00For
Northern Trust348,3140 00For
Man Group plc270,8710 00For
Hein Park Capital Management LP258,2320 00For
Victory Capital254,6260 00For
Rock Springs Capital Management LP204,5000 00For
SIRIOS CAPITAL MANAGEMENT L P199,0540 00For

No total is shown for the institutional-manager reports: their sum exceeds the total votes cast at the meeting. Showing the 25 largest; see all in the interactive database.

5. 3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 119,828,741AGAINST: 62,950
Details: description as filed, official tally, votes by 60 asset managers

Description as filed by funds: Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.

Surgery Partners, Inc.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for fiscal year 2026”): 119,828,741 for, 62,950 against — passed, per its Form 8-K filed June 5, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 60 asset managers below reported 30,390,263 for.

FOR
FOR: 30,390,263
Largest asset managers voting on “Ratification of the appointment of Ernst & Young LLP as the Company's independent registered public accounting” at Surgery Partners, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
JANUS INVESTMENT FUND12,979,6400 00For
Vanguard7,016,2440 00For
Legg Mason3,352,5800 00For
T. Rowe Price1,688,1130 00For
Fidelity1,330,7160 00For
Charles Schwab1,108,0790 00For
BlackRock943,4420 00For
Pacific Life555,2320 00For
Equitable215,1020 00For
TIAA159,7970 00For
Principal Exchange-Traded Funds139,3740 00For
WESMARK FUNDS120,0000 00For
Lincoln Financial82,9970 00For
Gabelli73,1970 00For
RBB FUND, INC.57,0740 00For
WisdomTree46,6180 00For
Northern Lights Fund Trust IV43,4090 00For
QUANTITATIVE MASTER SERIES LLC40,8310 00For
First Trust40,7380 00For
Global X36,1870 00For
Bridge Builder Trust33,9840 00For
Goldman Sachs33,2680 00For
JPMorgan31,5440 00For
GDL FUND28,0000 00For
FRANK FUNDS22,0000 00For

Showing the 25 largest of 60 asset managers. See all 60 in the interactive database.

Largest Surgery Partners, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 130,797,216 shares outstanding at the time of that meeting.

Fund voting reports: top Surgery Partners, Inc. shareholders by shares voted on “Approval, on an advisory basis, of the compensation paid by the Company to its named executive…”, 2025-2026
#Asset manager % of shares outstanding
1JANUS INVESTMENT FUND 9.92%
2Vanguard 5.36%
3Legg Mason 2.56%
4T. Rowe Price 1.29%
5Fidelity 1.02%
6Charles Schwab 0.85%
7BlackRock 0.72%
8Pacific Life 0.42%
9Equitable 0.16%
10TIAA 0.12%
Institutional-manager reports: top Surgery Partners, Inc. shareholders by shares voted on “Approval, on an advisory basis, of the compensation paid by the Company to its named executive…”, 2025-2026
#Asset manager % of shares outstanding
1BAIN CAPITAL INVESTORS LLC 38.19%
2Janus Henderson 20.66%
3OAK RIDGE INVESTMENTS LLC 9.29%
4Pentwater Capital Management LP 9.29%
5Clearbridge Investments, LLC 2.98%
6DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 2.38%
7T. Rowe Price 1.91%
8BlackRock 1.40%
9GLENVIEW CAPITAL MANAGEMENT, LLC 1.38%
10Charles Schwab 0.85%

Reported Surgery Partners, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Surgery Partners, Inc. holdings and ownership disclosed for the 2025-2026 proxy season
Holder % outstanding Disclosure
Bain Capital Investors, LLC 38.19% DEF14A
Janus Henderson Group PLC 9.97% DEF14A
Pentwater Capital Management LP 9.68% 13G
King Street Capital Management, L.P. 7.14% DEF14A
Vanguard Group 5.78% 13F
FMR LLC 5.00% DEF14A
BlackRock 4.33% 13F
Dimensional Fund Advisors 4.05% 13F
Citadel Advisors 1.72% 13F
FMR (Fidelity) 1.68% 13F

Percentages above are of 130,797,216 shares outstanding, as reported by Surgery Partners, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Surgery Partners, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.

At Surgery Partners, Inc.'s shareholder meeting held June 5, 2026, in the 2025-2026 proxy season, 206 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,203 separate fund positions. On the most widely held item on that ballot — Approval, on an advisory basis, of the compensation paid by the Company to its named executive… — Surgery Partners, Inc.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Surgery Partners, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 5, 2026.

Surgery Partners, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.